Kinetics, localization and isotype profile of antibody responses to immune stimulating complexes (Iscoms) containing human influenza virus envelope glycoproteins

Scandinavian Journal of Immunology

Volumn 43, Issue 2, 1996, Pages 164-172

  Sjolander A ^a   Bengtsson, K Lövgren ^b   Johansson, M ^b   Morein, B ^a,b  

^a NATIONAL VETERINARY INSTITUTE   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; ISCOM; SAPONIN; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOSTIMULATION; KINETICS; LYMPH NODE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 9044251204     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-29.x     Document Type: Article

References (37)

1. Cox JC, Coulter AR. Advances in adjuvant technology and application. In: Yong WK, ed. Animal Parasite Control Utilizing Biotechnology. Boca Raton, FL: CRC Press, Inc., 1992:49-111.
2. Morein B, Sundquist B, Höglund S, Dalsgaard K, Osterhaus A. Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature 1984;308:457-60.
3. Lövgren K, Morein B. The requirement of lipids for the formation of immunostimulating complexes (Iscoms). Biotechnol Appl Biochem 1988;10:161-72.
4. Claassen I, Osterhaus A. The iscom structure as an immune-enhancing moiety: experience with viral systems. Res Immunol 1992;143:531-41.
5. Höglund S, Dalsgaard K, Lövgren K, Sundquist B, Osterhaus A, Morein B. Iscoms and immunostimulation with viral antigens. In: Harris RJ, ed. Subcellular Biochemistry. New York: Plenum Publishing Corporation, 1989:39-68.
6. Sjölander A, Lövgren K, Ståhl S et al. High antibody responses in rabbits immunized with influenza virus ISCOMs containing a repeated sequence of the Plasmodium falciparum antigen Pf155/ RESA. Vaccine 1991;9:443-50.
7. Sundquist B, Lövgren K, Morein B. Influenza virus ISCOMs: antibody response in animals. Vaccine 1988;6:49-53.
8. Mumford JA, Jesset D, Dunleavy U et al. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccine. Vaccine 1994;12:857-63.
9. Sjölander A, Hansson M, Lövgren K, Wåhlin B, Berzins K, Perlmann P. Immunogenicity in rabbits and monkeys of influenza ISCOMs conjugated with repeated sequences of the Plasmodium falciparuin antigen Pf155/RESA. Parasite Immunol 1993;15:355-9.
10. Lövgren K. The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes. Scand J Immunol 1988;27:241-5.
11. Villacres-Eriksson M, Bergström-Mollaouglu M, Kåberg H, Morein B. Involvement of interleukin-2 and interferon-gamma in the immune response induced by influenza virus iscoms. Scand J Immunol 1992;36:421-6.
12. ten Hagen TLM, Sulzer AJ, Kidd MR, Lal AA, Hunter RL. Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines. J Immunol 1993;151:7077-85.
13. Brewer JM, Alexander J. Studies on the adjuvant activity of non-ionic surfactant vesicles: adjuvant-driven IgG2a production independent of MHC control. Vaccine 1994;12:613-9.
14. Chang SP, Nikaido CM, Hashimoto AC, Hashiro CQ, Yokota BT, Hui GSN. Regulation of antibody specificity to Plasmodium falciparum merozoite surface protein-1 by adjuvant and MHC haplotype. J Immunol 1994;152:3483-90.
15. Sedgwick JD, Czerkinsky C. Detection of cell-surface molecules, secreted products of single cells and cellular proliferation by enzyme immunoassay. J Immunol Methods 1992;150:159-75.
16. Lövgren K, Lindmark J, Pipkorn R, Morein B. Antigenic presentation of small molecules and peptides conjugated to a preformed iscom as carrier. J Immunol Methods 1987;98:137-43.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt Biochem 1976;72:248-54.
18. Rönnberg B, Fekadu M, Morein B. Adjuvant activity of nontoxic Quillaja saponaria Molina components for use in iscom-matrix. Vaccine 1995;13:1375-82.
19. Coffman RL, Seymour BWP, Lebman DA et al. The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev 1988;102:5-28.
20. Mosmann TR, Coffman RL, TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989;7:145-73.
21. Benner R, Meima F, van der Meulen GM, van Ewijk W. Antibody formation in mouse bone marrow, III. Effects of route of priming and antigen dose. Immunol 1974;27:747-60.
22. Benner R, Hijmans W, Haaijman JJ. The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation. Clin Exp Immunol 1981;46:1-8.
23. Benner R, van Oudenaren A, de Ruiter H. Antibody formation in mouse bone marrow, IX. Peripheral lymphoid organs are involved in the initiation of bone marrow formation. Cellular Immunol 1977;34:125-37.
24. Watson DL, Lövgren K, Watson NA, Fossum C, Morein B, Höglund S. Inflammatory response and antigen localization following immunization with influenza virus iscoms. Inflammation 1989;13:641-9.
25. Gray D, Skarvall H. B cell memory is short-lived in the absence of antigen. Nature 1988;336:70-3.
26. Gray D. Immunological memory. Annu Rev Immunol 1993;11: 49-77.
27. Vos Q, Claassen E, Benner R. Substantially increased sensitivity of the spot-ELISA for the detection of anti-insulin antibody-secreting cells using a capture antibody and enzyme-conjugated insulin. J Immunol Methods 1990;126:89-94.
28. Bennett B, Check IJ, Olsen MR, Hunter RL. A comparison of commercially available adjuvants for use in research. J Immunol Methods 1992;153:31-40.
29. Kenney JS, Hughes BW, Masada MP, Allison AC. Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J Immunol Methods 1989;121:157-66.
30. Wechsler DS, Kongshavn PAL. Heat-labile IgG2a antibodies affect cure of Trypanosoma musculi infection in C57BL/6 mice. J Immunol 1986;137:2968-72.
31. Nguyen L, Knipe DM, Finberg RW. Mechanism of virus-induced Ig subclass shifts. J Immunol 1994;152:478-84.
32. Coutelier J-P, van der Logt JTM, Heessen FWA, Warnier G, van Snick J. IgG2a restriction of murine antibodies elicited by viral infections. J Exp Med 1987;165:64-9.
33. Klaus G, Pepys M, Kitajima K, Askonas B. Activation of mouse complement by different classes of mouse antibody. Immunol 1979;38:687-95.
34. Fanger MW, Shen L, Graziano RF, Guyre PM. Properties of Fc receptors. Immunol Today 1989;10:92-9.
35. Heusser C, Anderson C, Grey H. Receptors for IgG: Subclass specificty of receptors on different mouse cell types and the definition of two distinct receptors on a macrophage cell line. J Exp Med 1977;145:1316-27.
36. Snapper CM, Peschel C, Paul WE. Interferon-γ stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J Immunol 1988;140:2121-7.
37. Snapper CM, Mond JJ. Towards a comprehensive view of immunoglobulin switching. Immunol Today 1993;14:15-7.